175 related articles for article (PubMed ID: 38061470)
1. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.
Xu Q; Zhuo K; Zhang X; Zhen Y; Liu L; Zhang L; Gu Y; Jia H; Chen Q; Liu M; Dong J; Zhou MS
Eur J Pharmacol; 2024 Jan; 962():176252. PubMed ID: 38061470
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice.
Zhang J; Xu Q; Ren F; Liu Y; Cai R; Yao Y; Zhou MS
Can J Physiol Pharmacol; 2021 Oct; 99(10):1000-1006. PubMed ID: 33852804
[TBL] [Abstract][Full Text] [Related]
3. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension.
Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS
Front Physiol; 2021; 12():732084. PubMed ID: 34650444
[TBL] [Abstract][Full Text] [Related]
4. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling.
Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q
Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167
[TBL] [Abstract][Full Text] [Related]
6. YAP/TAZ are Activated by Mechanical and Hormonal Stimuli in Myometrium and Exhibit Increased Baseline Activation in Uterine Fibroids.
Purdy MP; Ducharme M; Haak AJ; Ravix J; Tan Q; Sicard D; Prakash YS; Tschumperlin DJ; Stewart EA
Reprod Sci; 2020 Apr; 27(4):1074-1085. PubMed ID: 32056132
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
[TBL] [Abstract][Full Text] [Related]
8. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein mediates angiotensin II-induced vascular smooth muscle cell phenotypic modulation and hypertensive vascular remodelling.
Lin M; Yuan W; Su Z; Lin C; Huang T; Chen Y; Wang J
Cell Prolif; 2018 Dec; 51(6):e12517. PubMed ID: 30156340
[TBL] [Abstract][Full Text] [Related]
10. Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation.
Garoffolo G; Casaburo M; Amadeo F; Salvi M; Bernava G; Piacentini L; Chimenti I; Zaccagnini G; Milcovich G; Zuccolo E; Agrifoglio M; Ragazzini S; Baasansuren O; Cozzolino C; Chiesa M; Ferrari S; Carbonaro D; Santoro R; Manzoni M; Casalis L; Raucci A; Molinari F; Menicanti L; Pagano F; Ohashi T; Martelli F; Massai D; Colombo GI; Messina E; Morbiducci U; Pesce M
Circ Res; 2022 Jul; 131(3):239-257. PubMed ID: 35770662
[TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
[TBL] [Abstract][Full Text] [Related]
12. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
[TBL] [Abstract][Full Text] [Related]
13. YAP/TAZ Are Mechanoregulators of TGF-
Szeto SG; Narimatsu M; Lu M; He X; Sidiqi AM; Tolosa MF; Chan L; De Freitas K; Bialik JF; Majumder S; Boo S; Hinz B; Dan Q; Advani A; John R; Wrana JL; Kapus A; Yuen DA
J Am Soc Nephrol; 2016 Oct; 27(10):3117-3128. PubMed ID: 26961347
[TBL] [Abstract][Full Text] [Related]
14. Targeting YAP/TAZ mechanosignaling to ameliorate stiffness-induced Schlemm's canal cell pathobiology.
Li H; Kuhn M; Kelly RA; Singh A; Palanivel KK; Salama I; De Ieso ML; Stamer WD; Ganapathy PS; Herberg S
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C513-C528. PubMed ID: 38105758
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
16. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts.
Gao N; Lu L; Ma X; Liu Z; Yang S; Han G
Exp Dermatol; 2022 Mar; 31(3):320-329. PubMed ID: 34623712
[TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction.
Li H; Singh A; Perkumas KM; Stamer WD; Ganapathy PS; Herberg S
Invest Ophthalmol Vis Sci; 2022 Nov; 63(12):15. PubMed ID: 36350617
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells.
Aravamudhan A; Dieffenbach PB; Choi KM; Link PA; Meridew JA; Haak AJ; Fredenburgh LE; Tschumperlin DJ
Physiol Rep; 2024 Apr; 12(7):e15999. PubMed ID: 38610069
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
